Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424 Article

Fisher, Barbara J, Hu, Chen, Macdonald, David R et al. (2015). Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(3), 497-504. 10.1016/j.ijrobp.2014.11.012

Open Access International Collaboration

cited authors

  • Fisher, Barbara J; Hu, Chen; Macdonald, David R; Lesser, Glenn J; Coons, Stephen W; Brachman, David G; Ryu, Samuel; Werner-Wasik, Maria; Bahary, Jean-Paul; Liu, Junfeng; Chakravarti, Arnab; Mehta, Minesh

sustainable development goals

authors

publication date

  • March 1, 2015

webpage

published in

keywords

  • ADULTS
  • CANCER EORTC
  • EORTC PROGNOSTIC-FACTORS
  • EUROPEAN ORGANIZATION
  • II TRIAL
  • Life Sciences & Biomedicine
  • OLIGODENDROGLIOMA
  • Oncology
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • Radiology, Nuclear Medicine & Medical Imaging
  • SURVIVAL
  • Science & Technology
  • VINCRISTINE CHEMOTHERAPY

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 497

end page

  • 504

volume

  • 91

issue

  • 3